Martin Rimmer | CEO | Sirago Underwriting Managers | mail me |
South Africa’s open medical schemes have now published their contribution increases for 2027. Discovery Health Medical Scheme has announced a weighted average increase of 8.2%. Individual options will rise by between 7.4% and 8.9%. Momentum Medical Scheme and Medshield have both settled on 7.9%. Meanwhile, Bestmed has announced an average increase of 7.35%.
These figures sit well above the regulator’s guidance. In Circular 20 of 2026, the CMS suggested that schemes anchor increases at 3.8%. This aligns with the Reserve Bank’s inflation forecast, plus a reasonable allowance for utilisation. A year ago, its guidance stood at 3.3%. However, the weighted average increase it ultimately approved for 2026 was 8.1%.
Affordability will drive medical scheme decisions in 2027
The reality is that medical schemes must balance affordability, sustainability and value for members against rising healthcare costs. This remains a difficult task because healthcare provisioning costs are increasing significantly. Charges from healthcare providers are also rising ahead of general inflation. Consequently, schemes face increasing claims costs, higher utilisation and an ageing membership base. These pressures make medical scheme affordability an even greater concern for members.
For many scheme members, affordability will drive medical scheme decisions in 2027. More members will consider buying down to lower-cost options, such as core hospital plans. Others may move to network plans or restructure their healthcare cover to manage monthly expenses. However, they will still attempt to retain private hospital cover.
But lower-cost options can increase healthcare financial risk. More affordable options often make greater use of provider networks, co-payments, deductibles, formularies and managed-care rules. The bottom line is that medical schemes simply cannot keep pace with the rate of medical inflation while keeping premiums affordable.
The result is continual benefit erosion and increased member exposure to their own out-of-pocket funding. Members often don’t realise this until they enter hospital. That is when they discover how much of the bill their option will not pay in full.
These shortfalls represent the differences between what healthcare providers charge and what medical schemes reimburse for qualifying in-hospital procedures. Gap cover is designed to address these expenses.
For example, a medical scheme option may reimburse a provider at 100% of its tariff. However, a specialist may charge more than that amount. The member may then become responsible for the difference. This depends on the medical scheme’s terms and any applicable supplementary insurance policy.
What the gap claims are telling us
Our claims data indicates how quickly shortfall exposure has grown. The following analysis examines gap cover claims that we paid across a representative sample of 2,330 large-loss claims between 2020 and 2025. A large-loss claim is defined as R50,000 or more.
These claims cover every age group. They involve medical conditions ranging from joint disorders and cardiac emergencies to cancer, birth complications and respiratory conditions. In each case represented in this dataset, the medical scheme paid a portion of the treatment cost. We then paid an eligible shortfall under the relevant gap cover policy. Without that cover, the member may otherwise have had to pay the shortfall.
The claims span all age groups represented in the dataset:
| Age Group | No. of Claims | % of Total | Average Large Loss Gap Claimed | Highest Single Claim |
| 0 – 29 Years | 117 | 5% | R60,517 | R164,000 |
| 30 – 49 Years | 415 | 18% | R58,060 | R173,589 |
| 50 – 65 Years | 709 | 30% | R62,857 | R201,000 |
| 66 – 75 Years | 639 | 27% | R65,221 | R204,942 |
| 76+ Years | 450 | 19% | R64,755 | R211,293 |
| TOTAL | 2,330 | 100% | R62,900 |
Source: Sirago Underwriting Managers claims data 2020–2025. The ‘Amount Claimed’ represents the gap amount or shortfall that the medical scheme did not cover. Sirago paid this amount in addition to the medical scheme’s portion of the total treatment cost. These figures reflect the claims dataset described above. They should not be interpreted as a representation of the benefits payable under every gap cover policy.
Rising medical costs expose the limits of healthcare cover
In almost half of our large-loss gap claims in 2024, gap cover paid out more than the medical scheme. In one case, gap cover paid R126,771, while the medical scheme paid only R27,573. This represented just 18% of the total treatment bill.
The member paid a medical scheme premium of R8,000 a month. Their gap cover premium was R450. Without that gap policy, they would have been personally liable for R126,771. This example illustrates the potential financial exposure in that particular case. However, actual benefits and premiums vary by policy, member and claim circumstances.
The biggest driver remains the difference between what specialists charge and what schemes reimburse. This stems from the absence of a regulated ceiling on specialist or doctor fees in South Africa. Many specialists bill between 200% and 500% of the scheme rate. Meanwhile, many hospital or core medical scheme benefit options reimburse at only 100% of the tariff.
Co-payments and sub-limits are becoming a faster-growing problem. Schemes are using them as a cost lever, especially on elective orthopaedic surgery and internal prostheses. Once a sub-limit is used up, the member pays the rest.
Medical scheme affordability is changing how people buy cover
With salary increases struggling to match contribution increases, many scheme members are moving to cheaper options. I understand why.
The cost and medical scheme affordability pressures are real, and many are simply unavoidable. However, the danger lies in buying down without understanding what you have given up and where your risks are.
Lower-cost options usually depend on provider networks, lower reimbursement rates, tighter limits and more co-payments. A member who moves from a comprehensive plan to a network hospital plan still has hospital cover on paper. However, their exposure to shortfalls and even outright exclusions can rise sharply. This happens just as their financial cushion is getting thinner.
The greatest risk of underinsurance sits with people who make the cost-cutting decisions but don’t have the gap cover to protect them against the increased exposures that buying down brings.
There is a second critical consideration. Gap cover operates under regulation that allows it to respond only when the medical scheme has paid its portion of a claim. It cannot perform the role of a medical scheme benefit. Therefore, gap cover cannot pay for a procedure that the member’s medical scheme does not cover.
If your new option totally excludes a procedure, for example, it won’t fund an MRI or CT scan. Your gap policy can’t step in either. That is the biggest misconception we deal with. Gap cover tops up your scheme benefit where there is a shortfall or a co-pay on an in-hospital procedure. It doesn’t replace or substitute it.
For some families, a core hospital plan paired with strong gap cover can be a sensible structure. However, it only works if the two are properly matched with the input and advice of a professional healthcare financial adviser. The family must also be able to fund day-to-day costs themselves. These include GP visits, dentistry, chronic medication and other out-of-hospital health needs.
Managed care and networks are reshaping the shortfall
Schemes are relying more heavily on prevention, managed care and networks to contain costs. Prevention is good news for members, schemes and gap insurers. Earlier diagnosis usually means less invasive and less costly treatment. However, managed care also changes where shortfalls land.
Members who don’t follow scheme protocols or use a non-network hospital can face penalty co-payments. On some options, a co-payment on internal prostheses can reach 30% of the hospital account. However, not every gap policy covers penalty co-payments. Members therefore need to check their policy wording.
Prescribed Minimum Benefits (PMBs) add another layer of complexity. Several factors affect what the scheme pays. These include whether a condition qualifies, how the scheme applies its protocols and whether a designated service provider is involved.
PMB disputes are common. While they are being resolved, the member is recovering at home and the accounts keep arriving. For gap cover providers, staying relevant means keeping pace with scheme benefit design each year.
Every benefit cycle brings a new co-payment on one option and a reduced sub-limit on another. Our products have to respond to that, and we have to premium rate it responsibly. A gap policy designed around last year’s scheme rules can leave holes.
The risks on the horizon
Looking three to five years ahead, I expect medical technology to become one of the biggest sources of new shortfalls. Robotic-assisted surgery, transcatheter heart valve procedures and advanced cancer therapies are becoming more common. However, schemes often fund these treatments with attached limits or co-payments.
The medical scheme and gap cover membership base is also ageing. Since 2019, the average age of medical scheme members has risen from 35 to 37. This reflects the declining number of young South Africans joining schemes.
According to the Board of Healthcare Funders, total benefits paid by schemes grew from approximately R218 billion in 2022 to roughly R259 billion in 2024. Meanwhile, emigration and limited training capacity are contributing to a shrinking specialist pool. As demand for specialist skills grows, this shortage keeps upward pressure on fees.
I also flag a risk that threatens gap cover itself. We see the same procedure, by the same surgeon, billed at 200% of the scheme rate for one patient and 500% for another. Often, the only difference is that the second patient mentioned their gap policy.
A small number of providers are responsible for this practice. However, the cost is significant. This is where data matters. Claims analytics is our early-warning system. Tracking shortfalls by procedure, provider and scheme option shows us where risk is building before it becomes a crisis. It helps us spot billing that doesn’t add up and price fairly. It also gives brokers real cases to show clients.
Value only becomes visible at claim stage
Members usually judge gap cover by its monthly premium. However, I believe this is the wrong test. The premium is what you see. The benefit is what you need when the specialist’s account arrives. Comparing two policies on price alone tells you very little about what each one will actually pay.
The numbers make the point. A family with members under the age of 64 pays around R780 a month for our most comprehensive option at 2026 rates. A single average large-loss claim of R63,000 equals close to seven years of those premiums.
The industry must explain cover in real terms. Percentages above scheme rate mean little to most people. Show them an actual spinal operation or cancer diagnosis. Explain what the scheme paid and what the family would have owed. That changes the conversation.
Brokers and healthcare advisers sit at the centre of this process. A good adviser treats the scheme option and the gap policy as a single solution. They look for overlaps and for holes. Above all, they make sure the gap policy’s limits and co-payment cover match the option the client is actually on. This becomes especially important after a benefit option buy-down.
Members generally have until the beginning of December to change their scheme and/or option for 2027. Members are advised to use this window carefully. Don’t review your medical scheme in isolation. Sit down with your adviser, look at both policies together and ask one question: if I am admitted to hospital next year, what am I covered for? If you can’t answer that clearly, your healthcare funding plan needs detailed attention.


























